SGLT2i Use Tied to Lower Mortality in T2DM Across Ethnicities Tags Coronary artery disease SGLT-2 Inhibitor Read more about SGLT2i Use Tied to Lower Mortality in T2DM Across Ethnicities
Anagliptin Improved HbA1c Added to Metformin and Empagliflozin Tags hBA1c DPP-4 inhibitors Biguanide SGLT-2 Inhibitor Read more about Anagliptin Improved HbA1c Added to Metformin and Empagliflozin
Finerenone Benefit Persisted Across Baseline Diabetes Care Goals Tags Lipoprotein(a) hBA1c GLP-1 agonists SGLT-2 Inhibitor Read more about Finerenone Benefit Persisted Across Baseline Diabetes Care Goals
SGLT2i in Cardio-Renal Care: Bridging Heart & Kidney Protection Tags SGLT-2 Inhibitor Read more about SGLT2i in Cardio-Renal Care: Bridging Heart & Kidney Protection
Metabolic Shifts & Cardiovascular Foundations: The Expanding Role of SGLT2i Inhibitors Tags SGLT-2 Inhibitor Read more about Metabolic Shifts & Cardiovascular Foundations: The Expanding Role of SGLT2i Inhibitors
Dapagliflozin Added to Valsartan Improved Cardiorenal Measures in T2DM Tags SGLT-2 Inhibitor Read more about Dapagliflozin Added to Valsartan Improved Cardiorenal Measures in T2DM
SGLT2 Inhibitors Reduced Rejection After Heart Transplant Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Reduced Rejection After Heart Transplant
SGLT2 Inhibitors Linked to Lower CKD Risk Before Kidney Disease Tags Coronary artery disease SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Linked to Lower CKD Risk Before Kidney Disease
SGLT2i Use Shows Lower Stroke Risk in T2D With Retinopathy Tags Stroke hBA1c SGLT-2 Inhibitor Read more about SGLT2i Use Shows Lower Stroke Risk in T2D With Retinopathy
SGLT2i Linked to Lower Risk of ESKD in Nephrotic-Range Proteinuria Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about SGLT2i Linked to Lower Risk of ESKD in Nephrotic-Range Proteinuria